Arno Therapeutics (Apristor Onapristone XR Drug)

Business Data, Corporate Office and Headquarter Address

About

Arno Therapeutics (Apristor Onapristone XR Drug) is Buildings and Property in United States that focus on United States business. They cover business area such as Pennsylvania, United States, development, drug, breast cancer.

Business Type

Buildings and Property

Country

United States

Founded

-

Company Focus

United States

Website

-

Corporate Office and Headquarter Office address:

200 Route 31
No. 104
Flemington, NJ 08822
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

PennsylvaniaUnited Statesdevelopmentdrugbreast cancer

* We use standard office opening hours in near Arno Therapeutics (Apristor Onapristone XR Drug)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Arno Therapeutics (Apristor Onapristone XR Drug) Frequently Asked Questions

What or who is Arno Therapeutics (Apristor Onapristone XR Drug)?

Arno Therapeutics (Apristor Onapristone XR Drug) is Buildings and Property business from United States that founded in - ( years old in ), Arno Therapeutics (Apristor Onapristone XR Drug) business is focusing on United States.

Where is Arno Therapeutics (Apristor Onapristone XR Drug) headquarter and corporate office address?

Arno Therapeutics (Apristor Onapristone XR Drug) headquarter office and corporate office address is located in 200 Route 31 No. 104 Flemington, NJ 08822 United States.

Where is Arno Therapeutics (Apristor Onapristone XR Drug) country origins?

Arno Therapeutics (Apristor Onapristone XR Drug) was founded in United States.

What is United States business focus on?

In , Arno Therapeutics (Apristor Onapristone XR Drug) is currently focus on United States sector.

Disclaimer: This website is not affiliated with Arno Therapeutics (Apristor Onapristone XR Drug), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.